TRADE REMEDIES | 2026-07-12

Section 232 Pharmaceutical Tariffs Take Effect July 31

On April 2, 2026, President Trump issued a Section 232 proclamation imposing a 100 percent tariff on imported patented pharmaceuticals and their active ingredients — effective July 31, 2026 for a first tier of large manufacturers and September 29, 2026 for other importers, with generics exempt — reshaping costs for California life-sciences companies and importers.

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

The most consequential customs development facing California's life-sciences sector arrives on July 31, 2026, when a 100 percent Section 232 tariff on imported patented pharmaceuticals begins to bite. On April 2, 2026, President Trump issued a proclamation titled "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States," invoking Section 232 of the Trade Expansion Act of 1962, the national-security trade authority codified at 19 U.S.C. 1862. The proclamation im

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301